Literature DB >> 3280495

Compliance and blood pressure control.

L E Klein1.   

Abstract

Compliance with medical therapy in general is often low, and compliance with blood pressure treatment is no better. Numerous studies have shown that patients frequently drop out of treatment for hypertension. Furthermore, even when patients stay in treatment, they often take their medications in a way quite dissimilar from that prescribed. Identifying noncompliant patients is important but not always easy to accomplish. Pill counts, the "gold standard," are seldom practical in routine clinical practice. Assessing compliance by its biological effect is compromised by physiological diversity among patients. Assessing compliance from patient self-reports is limited in its accuracy but is more useful than many researchers and clinicians appreciate. Compliance behavior is affected by many factors. Complexity of medical regimen has some effect; the presence of drug side effects has surprisingly little. Contrary to what many clinicians think, increased age is often accompanied by increased medication compliance. Features of the doctor-patient relationship likely have an important effect on patient compliance, though our knowledge of these factors is still limited.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280495     DOI: 10.1161/01.hyp.11.3_pt_2.ii61

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  Daily regimen and compliance with treatment.

Authors:  B S Bloom
Journal:  BMJ       Date:  2001-09-22

Review 2.  Resistant hypertension and the Birmingham Hypertension Square.

Authors:  D C Felmeden; G Y Lip
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

3.  Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors.

Authors:  Philip S Wang; Rhonda L Bohn; Eric Knight; Robert J Glynn; Helen Mogun; Jerry Avorn
Journal:  J Gen Intern Med       Date:  2002-07       Impact factor: 5.128

Review 4.  The effect of antihypertensive treatment on the quality of later years.

Authors:  M A James; J F Potter
Journal:  Drugs Aging       Date:  1993 Jan-Feb       Impact factor: 3.923

Review 5.  Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension.

Authors:  Fadl Elmula M Fadl Elmula; Anne C Larstorp; Sverre E Kjeldsen; Alexandre Persu; Yu Jin; Jan A Staessen
Journal:  Front Physiol       Date:  2015-02-09       Impact factor: 4.566

Review 6.  Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments.

Authors:  Beatriz Pérez-Escamilla; Lucía Franco-Trigo; Joanna C Moullin; Fernando Martínez-Martínez; José P García-Corpas
Journal:  Patient Prefer Adherence       Date:  2015-04-13       Impact factor: 2.711

7.  Aortic Arch Baroreceptor Stimulation in an Experimental Goat Model: A Novel Method to Lower Blood Pressure.

Authors:  Jacobus F Benson; Johan P Schoeman; Frans J Venter; James A Ker; Gareth E Zeiler; Lynette Bester; Janet van Niekerk; Gregory R Tintinger
Journal:  Front Cardiovasc Med       Date:  2019-01-15

8.  Predictive validity of a medication adherence measure in an outpatient setting.

Authors:  Donald E Morisky; Alfonso Ang; Marie Krousel-Wood; Harry J Ward
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-05       Impact factor: 2.885

9.  Management of Hypertensive Patients With Multiple Drug Intolerances: A Single-Center Experience of a Novel Treatment Algorithm.

Authors:  Sotiris Antoniou; Manish Saxena; Nadya Hamedi; Catherine de Cates; Sakib Moghul; Satnam Lidder; Vikas Kapil; Melvin D Lobo
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-08-26       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.